Progress in vaccine development for infectious diseases-a Keystone Symposia report

Affiliations

• ¹ PhD Science Writer, New York, New York, USA.
• ² Morehouse School of Medicine, Atlanta, Georgia, USA.
• ³ Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
• ⁴ BioNTech SE, Mainz, Germany.
• ⁵ Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
• ⁶ Harvard Medical School, Boston, Massachusetts, USA.
• ⁷ Gilead Sciences, Foster City, California, USA.
• ⁸ CureVac AG, Tübingen, Germany.
• ⁹ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
• ¹⁰ Moderna, Cambridge, Massachusetts, USA.
• ¹¹ Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
• ¹² Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, New York, New York, USA.
• ¹³ Department of Pathology and Immunology; Center for Vaccines and Immunity to Microbial Pathogens; and The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs, Washington University School of Medicine, St. Louis, Missouri, USA.
• ¹⁴ Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
• ¹⁵ Koch Institute for Integrative Cancer Research; Department of Biological Engineering; and Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
• ¹⁶ Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, California, USA.
• ¹⁷ Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
• ¹⁸ Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
• ¹⁹ Department of Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.
• ²⁰ Genentech, South San Francisco, California, USA.
• ²¹ Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ²² Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France.
• ²³ Department of Biochemistry and Institute for Protein Design, University of Washington, Seattle, Washington, USA.
• ²⁴ Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
• ²⁵ Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
• ²⁶ Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
• ²⁷ Division of B Cell Immunology, German Cancer Research Center, Heidelberg, Germany.
• ²⁸ Institute for Immunity, Transplantation and Infection; Department of Pathology; and Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford University, Stanford, California, USA.
• ²⁹ Department of Immunology and Microbiology and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA.
• ³⁰ Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
• ³¹ Adimab, LLC, Lebanon, New Hampshire, USA.
• ³² New Hampshire and Adagio Therapeutics, Inc., Waltham, Massachusetts, USA.
• ³³ Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
• ³⁴ Centre for Prions and Protein Folding Diseases and Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
• ³⁵ Texas Children's Center for Vaccine Development, Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, USA.
• ³⁶ James A Baker III Institute for Public Policy, Rice University, Houston, Texas, USA.
• ³⁷ Department of Biology, Baylor University, Waco, Texas, USA.
• ³⁸ Hagler Institute for Advanced Study and Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, Texas, USA.
• ³⁹ Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.